SI2809349T1 - Imunogeni sestavek - Google Patents
Imunogeni sestavekInfo
- Publication number
- SI2809349T1 SI2809349T1 SI201331329T SI201331329T SI2809349T1 SI 2809349 T1 SI2809349 T1 SI 2809349T1 SI 201331329 T SI201331329 T SI 201331329T SI 201331329 T SI201331329 T SI 201331329T SI 2809349 T1 SI2809349 T1 SI 2809349T1
- Authority
- SI
- Slovenia
- Prior art keywords
- immunogenic composition
- immunogenic
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN281MU2012 | 2012-01-30 | ||
EP13743463.5A EP2809349B1 (en) | 2012-01-30 | 2013-01-29 | Immunogenic composition |
PCT/IB2013/050739 WO2013114268A1 (en) | 2012-01-30 | 2013-01-29 | Immunogenic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2809349T1 true SI2809349T1 (sl) | 2019-03-29 |
Family
ID=54259032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201331329T SI2809349T1 (sl) | 2012-01-30 | 2013-01-29 | Imunogeni sestavek |
Country Status (17)
Country | Link |
---|---|
US (1) | US9198977B2 (sl) |
EP (1) | EP2809349B1 (sl) |
JP (1) | JP6042455B2 (sl) |
KR (1) | KR101897317B1 (sl) |
CN (1) | CN104302315B (sl) |
BR (1) | BR112014018815B1 (sl) |
CA (1) | CA2863178C (sl) |
DK (1) | DK2809349T3 (sl) |
ES (1) | ES2707294T3 (sl) |
HU (1) | HUE040914T4 (sl) |
MX (1) | MX354103B (sl) |
PT (1) | PT2809349T (sl) |
RU (1) | RU2634405C2 (sl) |
SG (1) | SG11201404447WA (sl) |
SI (1) | SI2809349T1 (sl) |
TR (1) | TR201900778T4 (sl) |
WO (1) | WO2013114268A1 (sl) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101351870B1 (ko) * | 2005-06-27 | 2014-02-17 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 면역원성 조성물 |
BR112015011722B1 (pt) * | 2012-11-21 | 2022-08-09 | Serum Institute Of India Ltd | Método para preparar um polissacarídeo capsular de neisseria meningitidis x |
CN105744951B (zh) | 2013-08-24 | 2021-03-16 | 巴拉特生物技术国际有限公司 | 细菌疫苗及其制备方法 |
EP2921856B1 (en) | 2014-03-18 | 2016-09-14 | Serum Institute Of India Private Limited | A quantitative assay for 4-pyrrolidinopyridine (4-ppy) in polysaccharide-protein conjugate vaccines |
KR20240007690A (ko) | 2015-06-08 | 2024-01-16 | 세럼 인스티튜트 오브 인디아 프라이비트 리미티드 | 다당류-단백질 접합체의 흡착을 개선시키는 방법 및 그로부터 수득된 다가 백신 제제 |
EA039487B1 (ru) * | 2015-07-04 | 2022-02-01 | Бхарат Байотек Интернэшнл Лимитед | Комбинированные полисахаридные вакцинные композиции и способ получения бактериальных капсульных полисахаридов |
MX2018010920A (es) * | 2016-03-15 | 2019-03-06 | Msd Wellcome Trust Hilleman Laboratories Pvt Ltd | Nuevos conjugados de polisacarido-proteina, y procedimiento para obtener los mismos. |
CN106110316A (zh) * | 2016-06-27 | 2016-11-16 | 北京智飞绿竹生物制药有限公司 | 一种肺炎球菌结合物组合疫苗的制备方法 |
KR20190044663A (ko) | 2016-09-02 | 2019-04-30 | 사노피 파스퇴르 인크 | 네이세리아 메닌기티디스 백신 |
CN106397537B (zh) * | 2016-10-13 | 2020-01-07 | 李红臣 | 一种高效快速的多糖蛋白结合疫苗纯化分析方法 |
GEP20227408B (en) * | 2017-05-05 | 2022-08-25 | Serum Institute Of India Pvt Ltd | Method for removal of impurities from bacterial capsular polysaccharide based preparations |
BR112019027182A2 (pt) * | 2017-06-27 | 2020-06-30 | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. | nova composição de vacina conjugada de proteína - polissacarídeo multivalente e formulação da mesma |
US20200353064A1 (en) * | 2018-01-29 | 2020-11-12 | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Novel meningococcal vaccine composition and process thereof |
WO2019198096A1 (en) * | 2018-04-11 | 2019-10-17 | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Tetravalent meningococcal vaccine composition and process to prepare thereof |
JOP20200214A1 (ar) | 2019-09-03 | 2021-03-03 | Serum Institute Of India Pvt Ltd | تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها |
EP4192499A4 (en) | 2020-08-10 | 2024-09-25 | Inventprise Inc | MULTIVALENT PNEUMOCOCCAL GLYCOCONJUGATE VACCINES CONTAINING AN EMERGING 24F SEROTYPE |
CN118078981A (zh) * | 2024-04-26 | 2024-05-28 | 成都康华生物制品股份有限公司 | 一种基于双蛋白载体的五价脑膜炎球菌多糖结合疫苗的制备方法及其产品 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2763244B1 (fr) * | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | Composition vaccinale multivalente a porteur mixte |
OA12302A (en) * | 2000-06-29 | 2003-10-24 | Glaxosmithkline Biolog Sa | Multivalent vaccine composition. |
GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
GB0130215D0 (en) * | 2001-12-18 | 2002-02-06 | Glaxosmithkline Biolog Sa | Vaccine |
PL1961426T3 (pl) * | 2003-10-02 | 2012-03-30 | Gsk Vaccines S R L | Skojarzone szczepionki przeciwko zapaleniu opon mózgowo-rdzeniowych |
KR101351870B1 (ko) * | 2005-06-27 | 2014-02-17 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 면역원성 조성물 |
GB0513069D0 (en) * | 2005-06-27 | 2005-08-03 | Glaxosmithkline Biolog Sa | Immunogenic composition |
EP1967204B1 (en) * | 2005-09-01 | 2013-10-30 | Novartis Vaccines and Diagnostics GmbH | Multiple vaccination including serogroup c meningococcus |
JP5579387B2 (ja) * | 2005-12-22 | 2014-08-27 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 肺炎連鎖球菌莢膜多糖類コンジュゲートを含むワクチン |
GB0703369D0 (en) * | 2007-02-21 | 2007-03-28 | Health Prot Agency | Compositions Comprising Capsular Polysaccharides and Their Use as Vaccines |
JP5892944B2 (ja) * | 2009-12-17 | 2016-03-23 | フィナ バイオソリューションズ リミテッド ライアビリティ カンパニー | コンジュゲートワクチンの製造における多糖の活性化のための化学試薬 |
BR112014029313A2 (pt) * | 2012-05-22 | 2017-06-27 | Novartis Ag | conjugado de meningococos do sorogrupo x |
-
2013
- 2013-01-29 TR TR2019/00778T patent/TR201900778T4/tr unknown
- 2013-01-29 CN CN201380017781.9A patent/CN104302315B/zh active Active
- 2013-01-29 KR KR1020147024348A patent/KR101897317B1/ko active IP Right Grant
- 2013-01-29 RU RU2014134288A patent/RU2634405C2/ru active
- 2013-01-29 US US14/375,385 patent/US9198977B2/en active Active
- 2013-01-29 MX MX2014009250A patent/MX354103B/es active IP Right Grant
- 2013-01-29 BR BR112014018815-7A patent/BR112014018815B1/pt active IP Right Grant
- 2013-01-29 SI SI201331329T patent/SI2809349T1/sl unknown
- 2013-01-29 WO PCT/IB2013/050739 patent/WO2013114268A1/en active Application Filing
- 2013-01-29 EP EP13743463.5A patent/EP2809349B1/en active Active
- 2013-01-29 JP JP2014555364A patent/JP6042455B2/ja active Active
- 2013-01-29 DK DK13743463.5T patent/DK2809349T3/da active
- 2013-01-29 ES ES13743463T patent/ES2707294T3/es active Active
- 2013-01-29 HU HUE13743463A patent/HUE040914T4/hu unknown
- 2013-01-29 SG SG11201404447WA patent/SG11201404447WA/en unknown
- 2013-01-29 PT PT13743463T patent/PT2809349T/pt unknown
- 2013-01-29 CA CA2863178A patent/CA2863178C/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2863178A1 (en) | 2013-08-08 |
MX354103B (es) | 2018-02-13 |
RU2014134288A (ru) | 2016-03-20 |
HUE040914T4 (hu) | 2019-05-28 |
CA2863178C (en) | 2021-04-06 |
JP2015509111A (ja) | 2015-03-26 |
KR101897317B1 (ko) | 2018-09-11 |
RU2634405C2 (ru) | 2017-10-26 |
MX2014009250A (es) | 2015-03-19 |
US9198977B2 (en) | 2015-12-01 |
US20140377302A1 (en) | 2014-12-25 |
BR112014018815A8 (pt) | 2017-07-11 |
TR201900778T4 (tr) | 2019-02-21 |
EP2809349B1 (en) | 2018-12-19 |
CN104302315B (zh) | 2018-02-06 |
CN104302315A (zh) | 2015-01-21 |
BR112014018815A2 (sl) | 2017-06-20 |
EP2809349A1 (en) | 2014-12-10 |
ES2707294T3 (es) | 2019-04-03 |
WO2013114268A1 (en) | 2013-08-08 |
BR112014018815B1 (pt) | 2022-07-12 |
SG11201404447WA (en) | 2014-08-28 |
DK2809349T3 (da) | 2019-02-18 |
JP6042455B2 (ja) | 2016-12-14 |
KR20140123553A (ko) | 2014-10-22 |
PT2809349T (pt) | 2019-02-01 |
EP2809349A4 (en) | 2015-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1231412A1 (zh) | 免疫原性組合物 | |
ZA201503927B (en) | Immunogenic composition | |
SG11201404447WA (en) | Immunogenic composition | |
PL2647387T3 (pl) | Kompozycja szczepionki | |
IL238079A0 (en) | Immunogenic preparation | |
SG11201500979RA (en) | Immunogenic composition | |
PL2714910T3 (pl) | Kompozycja immunogenna | |
GB201223342D0 (en) | Immunogenic composition | |
GB201218660D0 (en) | Immunogenic composition | |
GB201204968D0 (en) | Immunogenic composition | |
GB201204851D0 (en) | Immunogenic composition |